SONDRA CURRY: Open Payments
NPI 1033655212 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$443 in 19 payments from 8 companies in 2025. Trend: 2023 $2,692 · 2024 $545 · 2025 $443
Food & beverage: $391Education: $51
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 5 | $132 |
| United Therapeutics Corporation | 4 | $123 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $59 |
| Actelion Pharmaceuticals US, Inc. | 2 | $45 |
| PFIZER INC. | 1 | $23 |
| BridgeBio Pharma, Inc. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $19 |
Products named: WINREVAIR, Remodulin, UPTRAVI, Adempas, Orenitram, VYNDAQEL, Attruby, CAMZYOS.
Industry payments across AL — which companies pay providers there.
